Inc.

Jun 19, 2020

Diabetic Peripheral Neuropathy Market is anticipated to grow with a CAGR of 12% by 2030 attributed to increasing DPN prevalence, and introduction to gene therapies in the pipeline. Diabetes prevalence has been on a gradual rise globally attributable to a paralleled rise in a sedentary lifestyle, obesity and inc...

Jun 15, 2020

Diabetic Peripheral Neuropathy Market is anticipated to grow with a CAGR of 12% for the study period of 2017-2030 Diabetic Peripheral Neuropathy (DPN) or Distal Symmetric Polyneuropathy (DSPN) is peripheral nerve dysfunction and damage in diabetic patients. It is a chiefly sensory neuropathy with autonomic nervo...

Jan 10, 2020

Anaphylaxis is a rare disease which can even result in life-threatening situations. Mostly the allergic reaction is due to food, insect stings, medications and latex.  Usually, the symptoms are expressed in one part of the body; however, in some instances, the reaction is severe. Sometimes, a specific type ...

Feb 11, 2019

Raynaud's Disease (RD), also called Raynaud's phenomenon, is a rare disorder of the blood vessels. The symptoms include when one is feeling cold or feeling stressed in some areas of the body like fingers and toes, blood can't reach to the epidermis (surface of the skin) and the affected areas turn wh...

Jul 09, 2018

Allergic Conjunctivitis (AC) is a common eye disorder characterized by the inflammation in the tissue that lines the inside of eyelid and outside of the eyeball called conjunctiva. It usually happens when a person’s eyes come into contact with an allergen, a substance that makes the body’s immune system to overreact...

Jul 18, 2014

On May 30, 2014, the U.S. Food and Drug Administration approved the first generic versions of Celebrex (celecoxib) capsules. Teva Pharmaceutical Industries received approval to market celecoxib capsules in 50 milligram, 100 mg, 200 mg, and 400 mg strengths, and has 180-day exclusivity on the 100 mg, 200 mg, and 400 ...